Siemens, Biogen to develop new MRI tools

|About: Biogen Inc. (BIIB)|By:, SA News Editor

Siemens (OTCPK:SIEGY +0.6%) and Biogen (BIIB +0.3%) are planning to jointly develop MRI applications with the intent of quantifying key markers of multiple sclerosis disease activity and progression.

To execute the strategy in the field of neurology, Siemens Healthineers will cooperate with Biogen and contribute to its strength in medical imaging.